- Details
- Description
Packaging Size:
30’s
Strength:
50 mg
Composition:
Enasidenib 50 mg
Treatment:
Anti-cancer medicine used for the treatment of certain types of acute myeloid leukemia (AML) with specific IDH2 mutations.
Form:
Tablet
Brand:
Enacitib
Quantity Unit:
Tablets
Manufacturer:
Ziska Pharmaceuticals Limited
Enacitib 50 contains Enasidenib 50 mg, a targeted anti-cancer medicine used in the treatment of certain types of acute myeloid leukemia (AML) associated with specific IDH2 mutations. It works by inhibiting the abnormal IDH2 enzyme and may help slow the growth of cancer cells. Enacitib 50 is a prescription medicine and should be used under the supervision of a qualified healthcare professional. Ziska Pharma lists it as an anti-cancer product for export only, with a pack size of 30’s.
